Company: MYGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000899923-25-000019
Chunk: 192

Company: MYRIAD GENETICS INC
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 192
---
— — 117.6 Stock-based compensation expense— 40.7 — — 40.7 Net loss— — — (263.3)(263.3)Other comprehensive income, net of tax— — 5.2 — 5.2 BALANCES AT DECEMBER 31, 2023$0.9 $1,415.5 $(3.7)$(629.5)$783.2 Issuance of common stock under stock-based compensation plans, net of shares exchanged for withholding tax— (7.5)— — (7.5)Stock-based compensation expense— 49.8 — — 49.8 Net loss— — — (127.3)(127.3)Other comprehensive income, net of tax— — 2.9 — 2.9 BALANCES AT DECEMBER 31, 2024$0.9 $1,457.8 $(0.8)$(756.8)$701.1 

See accompanying notes to consolidated financial statements.

80

Table of Contents

MYRIAD GENETICS, INC.

AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(in millions)

Years Ended December 31,202420232022CASH FLOWS FROM OPERATING ACTIVITIES:Net loss$(127.3)$(263.3)$(112.0)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization61.2 61.9 52.7 Non-cash lease expense9.5 11.3 11.7 Stock-based compensation expense49.8 40.7 38.1 Deferred income taxes(2.8)(4.0)(30.8)Unrecognized tax benefits2.5 3.4 (1.1)Impairment of goodwill and long-lived assets56.6 — 16.9 (Gain) loss on termination of lease(3.1)7.7 — Gain on acquisition(2.2)— — Other non-cash adjustments1.5 4.4 1.7 Changes in assets and liabilities:Prepaid expenses and other current assets(3.7)0.2 1.6 Trade accounts receivable(8.7)(12